Major clinical trials of adapt
| Therapy18 | ASTER19 | COMPASS20 | PROMISE21 | |
| Number of aspiration (n） | 43 | 192 | 134 | 204 |
| mTICI (2b/3） (%） | 70 | 85.4 | 92 | 93.1 |
| 90-day mRS (%） | 38 | 45.3 | 52 | 61 |
| 90-day mortality (%） | 12 | 19.3 | 22 | 7.5 |
| sICH (%） | 9.3 | 5.3 | 6 | 2.9 |
| ENT (%） | – | 3.7 | 0.75 | 1.5 |
| Aspiration catheters/devices | Separator 3D ACE | 5Max ACE 64 ACE68 Sofia | ACE 68 | ACE 68 ACE 64 ACE 60 |
| Puncture-to-reperfusion, time, mean (min) | – | 38 | 25 | 3 |
ADAPT, A Direct Aspiration First-pass Technique; ENT, Emboli in new territory; mRS, modified Rankin Scale; mTICI, modified thrombolysis in cerebral infarction; sICH, symptomatic intracranial haemorrhage.